Nanoparticles for Targeting of Prostate Cancer.

Current Pharmaceutical Design
Hooman YariVibhudutta Awasthi

Abstract

Prostate cancer (PCa) is the leading cause of death by cancer in men. Because of the drastic decline in the survival rate of PCa patients with advanced/metastatic disease, early diagnosis of disease and therapy without toxic side effects is crucial. Chemotherapy is widely used to control the progression of PCa at the later stages; however, it is associated with off-target toxicities and severe adverse effects due to the lack of specificity. Delivery of therapeutic or diagnostic agents by using targeted nanoparticles is a promising strategy to enhance accuracy and sensitivity of diagnosis of PCa and to increase efficacy and specificity of therapeutic agents. Numerous efforts have been made in past decades to create nanoparticles with different architectural bases for specific delivery payloads to prostate tumors. Major PCa associated cell membrane protein markers identified as targets for such purposes include folate receptor, sigma receptors, transferrin receptor, gastrin-releasing peptide receptor, urokinase plasminogen activator receptor, and prostate specific membrane antigen. Among these markers, prostate specific membrane antigen has emerged as an extremely specific and sensitive targetable marker for designing targeted na...Continue Reading

References

Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D Aragnol, L D Leserman
Sep 4, 1995·International Journal of Cancer. Journal International Du Cancer·J K TroyerG L Wright
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·R E CarterJ T Coyle
Jul 25, 1997·Biochimica Et Biophysica Acta·J A HardingS Zalipsky
May 4, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D GavrilovW R Folk
Feb 3, 2004·Journal of Cellular Biochemistry·Arundhati Ghosh, Warren D W Heston
Sep 8, 2004·International Journal of Cancer. Journal International Du Cancer·Sanjeeb K SahooVinod Labhasetwar
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Rajkumar BanerjeeLeaf Huang
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Nov 3, 2004·Cancer Research·Omid C FarokhzadRobert Langer
Nov 9, 2004·Biomacromolecules·Thommey P ThomasJames R Baker
Dec 13, 2005·Nature Reviews. Drug Discovery·Jia ZhouAlan P Kozikowski
Apr 12, 2006·Proceedings of the National Academy of Sciences of the United States of America·Omid C FarokhzadRobert Langer
Aug 15, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Tracy R DanielsManuel L Penichet
Jun 15, 2007·Journal of Medicinal Chemistry·Cyril BarinkaJacek Lubkowski
Jul 31, 2007·Cancer Treatment Reviews·Y Li, P J Cozzi
Feb 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Frank GuOmid C Farokhzad
Mar 19, 2008·Molecular Cancer Therapeutics·Sung Hee HwangEsther H Chang
Nov 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shanta DharStephen J Lippard
Jun 3, 2009·Methods in Molecular Biology·Frank GuOmid C Farokhzad
Jul 18, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sneha SundaramUday B Kompella
Mar 11, 2010·Methods in Molecular Biology·Juliana M ChanOmid C Farokhzad
Apr 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nripen ChandaRaghuraman Kannan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.